Did you guess correctly? In some studies, GLP-1 patients lose up to 45% of lean mass as a proportion of total weight lost. Why should individuals and organizations care? Our latest whitepaper breaks down how muscle loss can undermine long-term GLP-1 weight loss outcomes. Read it now. https://buff.ly/vuaFYNp
If you answered resistance training, you are correct. We’ll also accept “strength training.” Research shows that minimal-dose approaches to resistance training are very effective for stimulating muscle. Why is this such an important part of maintaining weight loss for GLP-1 users? To find out, read our latest whitepaper now. https://buff.ly/vuaFYNp
Heart Health is a year-round priority but this month we take a moment to celebrate #AmericanHeartMonth Heart disease is the leading cause of death in the U.S., with someone suffering from a heart attack approximately every 40 seconds. ✨The good news: many of these events are linked to modifiable risk factors. At Omada, our cardiometabolic specialists focus on the everyday drivers of cardiovascular risk: high blood pressure, high cholesterol, diabetes, and obesity. ❤️ By helping members understand and take action,we see meaningful improvements in cardiometabolic risk profiles over time. ❤️ Learn more about our cardiovascular care: https://buff.ly/HlMFDkE
Good news in heart health? Yes, it exists. This Heart Health Month, we're celebrating the wins: AI detecting irregular heartbeats, fashionable wearables monitoring blood pressure 24/7, and smart tools making heart-healthy eating actually sustainable. The tech revolution in cardiovascular care is here, and it's giving hope to the nearly 50% of U.S. adults living with heart disease. In this month’s Proof Points, VP of Clinical Innovation & Quality, Justin Wu, MD, dives into the latest innovations in heart health. Read it here →
Don't miss Thomas Tsang, MD, MPH at MIT Sloan Healthcare and BioInnovations Conference (SHBC) this Friday, 2/27!
Black History Month is especially meaningful this year as we mark 100 years since Dr. Carter G. Woodson founded Black History Week in 1926—a celebration that has grown into a month honoring Black excellence, resilience, and achievement. Throughout February, our Onyx ERG is leading “100 Years of Black History: A Journey Through Time,” a four-week exploration of the moments, movements, and innovators that have shaped our nation—and continue to shape our work in health equity today. We’re grateful to our Black colleagues and Onyx ERG leaders for creating spaces to learn, reflect, and act at Omada and in our communities. #BlackHistoryMonth
🫀 February is American Heart Month, and the American Heart Association's new statistics tell an important story about where we’re headed in the U.S. Senior Director of Clinical Affairs, Kevin Masci, Pharm D, breaks it down in this ~2-minute video. 👇
🚨We’ve expanded our cardiometabolic platform with Omada for Cholesterol to deliver between-visit support for the many adults whose LDL remains uncontrolled under usual care. High cholesterol is often silent, but is a primary driver of cumulative cardiovascular risk, frequently appearing alongside obesity, hypertension, and diabetes. Bringing dedicated cholesterol management into our integrated between‑visit model means employers and health plans can address more cardiovascular risk through one partner for cardiometabolic care, not another standalone program to manage. Learn more in the press release: https://buff.ly/qITp9P8
Omada’s Chief Privacy and Regulatory Officer, Lucia Savage is heading to #ViVE2026 to dig into how specialty care is being rebuilt around virtual and AI-enabled models—without losing sight of privacy, quality, or trust. In the “Supercharged Specialty Care” session, Lucia will weigh in on: ⚡What CMS’s ACCESS model could mean for Medicare beneficiaries ⚡How fee-for-service Medicare experiments may spill over into commercial coverage ⚡Where AI can safely support specialty care—and where these tools create compliance risk See you at the Malibu Stage on Tuesday, 2/24 https://lnkd.in/egKkTS2R
As a digital diabetes prevention provider over the last decade, we’ve seen first-hand how diabetes doesn’t “act” alone. Our Omada for Diabetes members often manage multiple chronic conditions at the same time, requiring care that adapts to their individual circumstances. One co-condition of diabetes is heart disease. In fact, people with diabetes are two to four times more likely to develop cardiovascular disease. In a recent Proof Points, Diabetes Care Team Senior Manager Carolyn Salter, RD, LD, CDCES dives into the connection between diabetes and high cholesterol, the importance of knowing your numbers, and why accepting support is crucial for reducing your risk of complications. Read here and share with someone who could benefit from this information. https://lnkd.in/eaQWJxgk
